A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors

NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - Cancer discovery, 2013 - AACR
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.

NS Jahchan, JT Dudley, PK Mazur, N Flores… - Cancer …, 2013 - europepmc.org
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug-repositioning bioinformatics approach querying a …

[HTML][HTML] A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors

NS Jahchan, JT Dudley, PK Mazur, N Flores… - Cancer …, 2013 - ncbi.nlm.nih.gov
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug-repositioning bioinformatics approach querying a …

[PDF][PDF] A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - researchgate.net
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …

A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

NS Jahchan, JT Dudley, PK Mazur, N Flores… - Cancer …, 2013 - escholarship.org
UnlabelledSmall cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung
cancer with high mortality. We used a systematic drug repositioning bioinformatics approach …

A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - Cancer …, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Small cell lung cancer (SCLC) is an
aggressive neuroendocrine subtype of lung cancer with high mortality. We used a …

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors

NS Jahchan, JT Dudley, PK Mazur… - Cancer …, 2013 - mdanderson.elsevierpure.com
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …

[PDF][PDF] A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - academia.edu
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors

NS Jahchan, JT Dudley, PK Mazur… - Cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …

[PDF][PDF] A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

NS Jahchan, JT Dudley, PK Mazur, N Flores, D Yang… - Citeseer
Small cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with
high mortality. We used a systematic drug repositioning bioinformatics approach querying a …